Literature DB >> 1743802

Striving for standards in bioequivalence assessment: a review.

H U Schulz1, V W Steinijans.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1743802

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN： 0174-4879


× No keyword cloud information.
  7 in total

Review 1.  Controversies in bioequivalence studies.

Authors:  V W Steinijans; D Hauschke; J H Jonkman
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

Review 2.  Metrics for the evaluation of bioequivalence of modified-release formulations.

Authors:  Laszlo Endrenyi; Laszlo Tothfalusi
Journal:  AAPS J       Date:  2012-08-22       Impact factor: 4.009

3.  Comparative pharmacokinetics of two nifedipine products in capsule form following single oral administration in healthy volunteers.

Authors:  N M Rawashdeh; A H Battah; Y M Irshaid; M K al-Qato
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jul-Sep       Impact factor: 2.441

4.  Bioequivalence testing of a new tablet formulation of generic fluoxetine.

Authors:  D Jovanović; V Kilibarda; S Dordević; M Jovanović; J Jovic-Stosić; D Srdić; T Knezević
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Jan-Mar       Impact factor: 2.441

5.  A survey of the likelihood approach to bioequivalence trials.

Authors:  Leena Choi; Brian Caffo; Charles Rohde
Journal:  Stat Med       Date:  2008-10-30       Impact factor: 2.373

6.  Clinical pharmacological equivalence of a novel FCH-free GTN spray with low ethanol content vs a FCH-containing GTN spray.

Authors:  C de Mey; K Erb; T Zimmermann; H Mutschler; H Blume; G G Belz
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

7.  Bioequivalence: tried and tested.

Authors:  R Schall; L Endrenyi
Journal:  Cardiovasc J Afr       Date:  2010 Mar-Apr       Impact factor: 1.167
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.